Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Pancreatic cancer, Secondary cancers
Closed
Phase 3
This trial is looking at a new drug called AM0010 for cancer of the pancreas that has spread (advanced pancreatic cancer).
It is open to people with advanced pancreatic cancer that continued to grow during or after having gemcitabine.
Recruitment start: 21 July 2017
Recruitment end: 28 February 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Pippa Corrie
ARMO BioSciences
Last reviewed: 28 February 2019
CRUK internal database number: 15405
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
